We are live on ! Find out more
ASTH icon

Astrana Health

189 hedge funds and large institutions have $1.47B invested in Astrana Health in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 69 increasing their positions, 59 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,487% more call options, than puts

Call options by funds: $35.4M | Put options by funds: $1.37M

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

57% more capital invested

Capital invested by funds: $935M → $1.47B (+$531M)

17% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 59

10% more funds holding

Funds holding: 172189 (+17)

3.88% more ownership

Funds ownership: 41.12%45% (+3.9%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
189
Holders Change
+17
Holders Change %
+9.88%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
69
Reduced
59
Closed
14
Calls
$35.4M
Puts
$1.37M
Net Calls
+$34M
Net Calls Change
+$8.25M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$370M -$108K -2,207 -0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$270M -$2.6M -52,885 -1%
State Street
3
State Street
Massachusetts
$92M +$269K +5,474 +0.3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$59M +$120K +2,451 +0.2%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$54.7M +$638K +12,993 +1%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$48.4M +$41M +833,653 +43,419%
3C
7
325 Capital
New York
$39.5M +$2.93M +59,562 +10%
SW
8
SteelPeak Wealth
California
$39.4M -$353K -7,192 -1%
Jane Street
9
Jane Street
New York
$39M +$29.2M +594,171 +746%
Loomis, Sayles & Company
10
Loomis, Sayles & Company
Massachusetts
$30.3M +$25.7M +522,109 New
NAM
11
NorthCrest Asset Manangement
Minnesota
$26.7M +$12.9M +262,332 +132%
Charles Schwab
12
Charles Schwab
California
$25.9M +$1.24M +25,307 +6%
Northern Trust
13
Northern Trust
Illinois
$24.6M -$110K -2,239 -0.5%
Morgan Stanley
14
Morgan Stanley
New York
$19.8M +$228K +4,650 +1%
FWIA
15
Fort Washington Investment Advisors
Ohio
$17.4M -$9.85M -200,560 -40%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$15.6M -$2.34M -47,604 -15%
Goldman Sachs
17
Goldman Sachs
New York
$15M +$5.13M +104,412 +68%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$14.8M -$430K -8,742 -3%
BG
19
Bellevue Group
Switzerland
$14.7M +$175K +3,565 +1%
Invesco
20
Invesco
Georgia
$14M +$1.62M +33,038 +16%
AWS
21
Atria Wealth Solutions
New York
$13.8M
Principal Financial Group
22
Principal Financial Group
Iowa
$13.4M +$512K +10,419 +5%
FMI
23
F/M Investments
District of Columbia
$11.7M -$44.7K -910 -0.4%
WP
24
Woodline Partners
California
$10.6M +$4.47M +91,006 +99%
Diamond Hill Capital Management
25
Diamond Hill Capital Management
Ohio
$8.24M +$1.91M +38,826 +38%

ASTH Hedge Fund Activity: Q3 2024 in Review

189 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2024, worth a combined $1.47B — up 57% from $935M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ASTH positions and 14 closed out — a net gain of 17 holders — while 69 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $41M. The largest seller was Point72 Asset Management, cutting an estimated $11.4M.

  • 189 institutional investors held Astrana Health (ASTH) as of Q3 2024, up from 172 in Q2 2024.
  • Funds reported $1.47B of Astrana Health stock for Q3 2024, up 57% quarter-over-quarter.
  • 31 funds opened new Astrana Health positions in Q3 2024 and 14 closed out, a net change of +17 holders.
  • The largest Astrana Health buyer in Q3 2024 was Fidelity Investments, an estimated $41M added.
  • The largest Astrana Health seller in Q3 2024 was Point72 Asset Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2024.